Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma

Abstract

Small cell carcinoma of the prostate (PSCC) is a highly aggressive malignancy that often develops in patients previously treated with hormonal therapy for metastatic prostatic acinar adenocarcinoma. The TMPRSS2-ERG gene rearrangement is highly specific for prostate cancer and shared by PSCC; however, the role of androgen receptor (AR) gene alterations and interaction with TMPRSS2-ERG rearrangement are incompletely understood in PSCC. Sixty-one cases of PSCC were examined for AR gene copy number and TMPRSS2-ERG rearrangement by fluorescence in situ hybridization (FISH) and AR protein expression by immunohistochemistry. Of 61 cases of PSCC, 51% (31/61) demonstrated increased AR gene copy number (FISH+), 54% (33/61) were positive for TMPRSS2-ERG gene fusion, and 38% (23/61) showed AR protein expression. Of the 31 AR FISH+ cases, 23 also showed TMPRSS2-ERG gene fusion, and 16 expressed AR protein. Of the 33 cases with TMPRSS2-ERG fusion, 28 were AR FISH+ or expressed AR protein. Statistically significant correlations were observed between AR gene copy number or AR protein expression and TMPRSS2-ERG gene fusion (P = 0.001 and P = 0.03, respectively). In summary, high AR gene copy number emerges during the development of PSCC, often in association with TMPRSS2-ERG rearrangement. This potential mechanism warrants further study. Improvement will come from understanding the biology of the disease and integrating new therapies into the treatment of this rare and aggressive tumor.

RNA‐based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP‐2 upregulation for a subsequent prostate cancer diagnosis

“…Detection of higher AR transcription in T2E fusion positive patients is likely to be explained by this association. Similarly, the increased AR gene copy number was associated with T2E rearrangement in prostatic small cell carcinoma . These results were also confirmed by prostate cancer cell culture studies .…”

“…Similarly, the increased AR gene copy number was associated with T2E rearrangement in prostatic small cell carcinoma. 55 These results were also confirmed by prostate cancer cell culture 59 Although these findings were important in terms of confirming the compatibility of the study, we revealed that KLK3 did not predict PC risk at the RNA level in ASAP-diagnosed patients.…”

Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer

“…Thus, the possible H-score ranged from 0 to 300 (20). Currently there is no consensus cutoff for p53 immunohistochemistry in CRC.…”

Neuroendocrine differentiation in prostate cancer: Novel morphological insights and future therapeutic perspectives

“…ERG (ETS-related gene) and TMPRSS2 are 2 of the 29 members of the ETS family of genes, which plays a crucial role in the development of different tissues as well as cancer progression. Approximately half of the usual PCa and SmCC present TMPRSS2-ERG gene fusion [36] or other ERG gene rearrangements [36][37][38]. Tan and colleagues evaluated the status of RB1, TP53, and PTEN in SmCC.…”